|
 |
| EXPERIMENTAL RESEARCH ARTICLE |
|
|
|
| Year : 2021 | Volume
: 53
| Issue : 5 | Page : 377-383 |
| |
Evaluation of anticancer activity of Clerodendrum viscosum leaves against breast carcinoma
Anil Khushalrao Shendge, Tapasree Basu, Nripendranath Mandal
Division of Molecular Medicine, Bose Institute, Kolkata, West Bengal, India
| Date of Submission | 11-Oct-2019 |
| Date of Decision | 07-Aug-2020 |
| Date of Acceptance | 28-Aug-2021 |
| Date of Web Publication | 24-Nov-2021 |
Correspondence Address:
Prof. Nripendranath Mandal
Division of Molecular Medicine, Bose Institute, P-1/12 CIT Scheme - VIIM, Kolkata - 700 054, West Bengal
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijp.IJP_565_19
INTRODUCTION: The use of natural resources as medicines for cancer therapies has been described throughout history in the form of traditional medicines. However, many resources are still unidentified for their potent biological activities. Clerodendrum viscosum is a hill glory bower reported as a remedy against oxidative stress, skin diseases, and intestinal infections.
MATERIALS AND METHODS: We have collected the C. viscosum leaves and used for the preparation of 70% methanolic extract (CVLME). Then, CVLME has been confirmed for anticancer properties on various cancer cell lines by evaluating cytotoxicity, cell cycle analysis, induction of ROS and apoptosis, and nuclear fragmentation. Further, the phytochemical analysis of CVLME was evaluated through high-performance liquid chromatography.
RESULTS: Cell proliferation assay revealed the selective cytotoxicity of CVLME against breast cancer cell line (MCF-7). The FACS-based cell cycle analysis showed increased subG1 (apoptosis) population dose dependently. Further, the apoptosis-inducing effect of CVLME was confirmed by annexin staining. Flow cytometry and confocal microscopy revealed the selective ROS generation upon CVLME treatment. The confocal-based morphological study also revealed condensed and fragmented nuclear structure in CVLME-treated MCF-7 cells. Phytochemical investigations further indicated the presence of tannic acid, catechin, rutin, and reserpine which might be the reason for the anticancer activity of CVLME.
CONCLUSION: The above-combined results revealed the anticancer effect of CVLME, which may be due to the selective induction of ROS in breast carcinoma.
Keywords: 70% methanolic extract, anticancer, Clerodendrum viscosum, medicinal plant, ROS induction
How to cite this article:
Shendge AK, Basu T, Mandal N. Evaluation of anticancer activity of Clerodendrum viscosum leaves against breast carcinoma. Indian J Pharmacol 2021;53:377-83 |
How to cite this URL:
Shendge AK, Basu T, Mandal N. Evaluation of anticancer activity of Clerodendrum viscosum leaves against breast carcinoma. Indian J Pharmacol [serial online] 2021 [cited 2023 Jun 3];53:377-83. Available from: https://www.ijp-online.com/text.asp?2021/53/5/377/331082 |
| » Introduction | |  |
The free radicals are mainly categorized into reactive oxygen species (ROS) and reactive nitrogen species (RNS). Both formed through metabolic reactions and modulate numerous cellular processes. Unfortunately, these are highly reactive molecules, and at high concentrations, they cause damage to lipids, proteins, and DNA which ultimately leads to initiate various detrimental diseases including cancer.[1],[2],[3] Cancer is a state of the body with unrestrained multiplication of cells. It can develop almost everywhere in the human body. Among 36 cancer types, breast cancer is on top with 49.9% incidences and the second-highest 12.9% crude mortality rate.[4],[5] The current treatments for cancer include chemotherapy and radiation therapy, but these therapies are very expensive and can leave the patients with enormous side effects. In recent years, natural products have been widely used for cancer therapies to overcome the cost and side effects of chemo and radiation therapies. Natural products are documented as a major source of drugs in several diseases including cancers. Among the natural resources, plants are rich in various phytochemicals and more than 75% of the drugs against various infections have been isolated from plant resources. The natural antioxidants from plants could alter the microenvironment and modify the behavior of cancer cells[6],[7] and thus may be useful in the treatment of cancer.[8] Major anticancer drugs isolated from plants are irinotecan, paclitaxel, vincristine, and etoposide.[9] Despite the discovery of many chemically prepared as well as naturally originated drugs, it is necessary to discover new anticancer agents with less toxic and more effective in treatment. The genus Clerodendrum is widely distributed and has been reported for its enormous activities.[10],[11],[12],[13],[14],[15] Clerodendrum viscosum (C. viscosum), sometimes called a Clerodendrum infortunatum, is a hill glory bower and enlisted as a prominent medicinal plant in Ayurveda for ages. C. viscosum has been reported as a remedy against various skin diseases, snake bite, scorpion sting, intestinal infections, and kidney dysfunctions.[16],[17] In this study, we have prepared the 70% methanolic extract (CVLME). Further, CVLME was used to test its detailed anticancer activity against MCF-7.
| » Materials and Methods | | |
Reagents and chemicals
The HiMedia Laboratories (India) supplied cell culture media (DMEM and F-12), Amphotericin-B, and other Antibiotics. HyClone Laboratories, Inc., UT and Alexis biochemical, San Diego, CA, USA supplied FBS and DCFH-DA, respectively. WST-1 reagent and apoptosis staining kit (Annexin-V FLUOS) were bought from Roche Diagnostics (Mannheim, Germany). Other reagents including DAPI stain and RNAase A were provided by MP Biomedicals (France).
Collection of plant material
Leaves of C. viscosum were collected from the North Bengal University campus and other area near Siliguri, India and validated by Prof. A. P. Das (Taxonomist of the University of North Bengal). The sample was stored with the accession number of 9617 at the Herbarium of the University. The C. viscosum leaves were further processed, and 70% methanol extract was prepared according to a previously published method and named as CVLME.[18]
Cell lines and culture
The WI-38, MCF-7, U87, HeLa, and A549 cell lines were attained from NCCS, India. Cell lines were supplemented with appropriate media. Normal fibroblast (WI-38), human breast adenocarcinoma (MCF-7), cervical carcinoma (HeLa), and glioblastoma (U87) were grown in DMEM. Moreover, F-12 Ham's medium was used to grow lung carcinoma (A549) cell line. All the media were supplemented with appropriate antibiotics and 10% (v/v) FBS. All the cell lines were maintained in a CO2 incubator having constant supply of 5% CO2 and 37°C temperature.
Cell toxicity with WST-1 reagent
The cytotoxicity of CVLME on various cell lines was assessed according to earlier described protocol[19] using the WST-1 reagent. The reading was measured at 460 nm.
Cell cycle distribution and apoptosis study
The cells (MCF-7) were treated with various doses of CVLME and analyzed the cell cycle and apoptosis inducing effect according to a previously mentioned protocol.[19] The different phases of cell cycle were evaluated on a flow cytometer (FACS Verse). Further, the Annexin Staining kit was used to evaluate the apoptosis-inducing effect of CVLME on MCF-7 cells. The apoptotic population was also analyzed with a flow cytometer (FACS Verse).
Morphological evaluation using DAPI
DAPI stain was used to observe the nuclear morphology upon treatment with CVLME. For that, cells were seeded and incubated with CVLME (200 μg/ml) in a CO2 incubator for the period of 48 h. Cells were then incubated with paraformaldehyde (4%) for 20 min for the fixation, followed by cell permeabilization with Triton X-100 (0.5%). Finally, the cells were incubated with 10 μg/ml DAPI solution and observed using a confocal microscope.
Determination of ROS levels
Fluorescent dye DCFH-DA was used to evaluate the effect of CVLME on ROS induction in MCF-7 and WI-38 cells. The cells were incubated with CVLME (0–300 μg/ml) for 24 h and further stained with DCFH-DA. After washing, the cell samples were observed using FACS Verse. In addition, to flow cytometric observations, we have reconfirmed the results of CVLME-induced ROS in MCF-7 using a confocal microscopy. Briefly, 1 × 105 cells were seeded and treated with CVLME (200 μg/ml) for 24 h. After incubation, treated cells were again incubated using fluorescent dye DCFH-DA solution for the period of 30 min at RT. After the proper washing, the coverslip containing cell samples was fixed on a glass slide and analyzed using a confocal microscope.
High-performance liquid chromatography analysis of CVLME
High-performance liquid chromatography (HPLC) was performed to analyze the phytocompounds present in CVLME. The previously published protocol was used for sample preparation, HPLC run, and analysis.[19]
Statistical analysis
Cytotoxicity data were shown as the mean ± standard deviation (SD) of six independent readings. The experiments accomplished using the FACS as the mean ± SD of three independent readings. The statistical analysis was performed using KyPlot version 2.0 beta 15 (32 bit) (KyensLab Inc., Tokyo, Japan). The IC50 values were calculated by following previously published protocol.[19]
| » Results | | |
Cell toxicity test
The toxic effect of CVLME on A549, MCF-7, U87, HeLa, and WI-38 was assessed with the help of WST-1 chromogenic reagent.[Figure 1]a shows that the CVLME selectively kill breast carcinoma cells (MCF-7) and it was nontoxic to other cancer cell lines as well as noncancerous fibroblast cell line WI-38. The highest dose of CVLME showed 40.15% of cell viability in MCF-7 cells. The graphical representation of IC50 values of CVLME against various cell lines are shown in [Figure 1]b. | Figure 1: Cytotoxic potential of CVLME on A549, MCF-7, U87, HeLa, and normal fibroblast cells WI-38. (a) Cell viability was determined with WST-1 cell proliferation reagent. Results were expressed as cell viability (% of control). (b) The graphical representation of IC50 values of CVLME against indicated cell lines. All data are expressed as mean ± standard deviation (n = 6)
Click here to view |
Evaluation of cell cycle phases
MCF-7 cells were treated with CVLME to analyze the cell cycle profile through a flow cytometer. After 48 h of treatment of CVLME, the cell cycle analysis was done and the phase distribution profile showed the induction of apoptotic peak (sub G1 phase) from 50 μg/mL treatment. The highest dose of CVLME showed 15.02% population of sub G1 phase with a slight increase of synthetic (S) phase population in the MCF-7 cell line [Figure 2]. | Figure 2: Flow cytometric analysis of MCF-7 cells treated with CVLME. Cell cycle phase distribution of Sub-G1, G1, S and G2/M phases of control MCF-7 cells (a) and treated MCF-7 cells with the indicated doses of CVL (b-f) ME for 48 h
Click here to view |
Annexin V/PI staining
The dose-dependent CVLME treatment increases apoptotic population of MCF-7 cells, which was confirmed by the apoptosis staining kit Annexin. [Figure 3]a shows that the 99.81% population was FITC negative, whereas the apoptotic cells gradually increases with increasing dose. As shown in [Figure 3]f, the highest dose of CVLME phase distribution 39.91% FITC positive population (early apoptosis). | Figure 3: Apoptosis detection of MCF-7 cells by Annexin V/PI staining with different concentrations of CVLME. (a) 0 μg/ml, (b) 50 μg/ml, (c) 100 μg/ml, (d) 150 μg/ml, (e) 200 μg/ml, (f) 300 μg/ml.
Click here to view |
Morphological evaluation through DAPI
As shown in [Figure 4], normal intact nuclear morphology was observed in untreated MCF-7 cells. However, abbreviated nuclei were detected on treatment with 200 μg/mL of CVLME. | Figure 4: Morphological Assessment of CVLME-treated MCF-7 cells through confocal microscopy. Nuclei were stained with DAPI and observed under a confocal microscope in comparison to the untreated cells. The white arrows indicate ruptured cells with fragmented nuclei
Click here to view |
Measurement of ROS levels
Upon CVLME treatment, the DCFH-DA-stained cells (MCF-7 and WI-38) were observed using a flow cytometer. As revealed from [Figure 5]a, the CVLME treatment does not induce any ROS amount in normal lung fibroblast cell line WI-38. However, the dose-dependent increase in ROS was detected in treated MCF-7 cells. The highest dose of CVLME increases nearly 3.7 fold of ROS in MCF-7 as compared to control cells. The CVLME-mediated induction of ROS was further reconfirmed through a confocal microscopy. As shown in [Figure 5]b, a negligible amount of ROS was detected in untreated MCF-7 cells, whereas green fluorescence generated in CVLME (200 μg/mL) treated MCF-7 cells indicated the ROS generation. | Figure 5: ROS analysis of CVLME treated MCF-7 and WI-38 cells through FACS and confocal microscopy. (a) Intracellular ROS levels were examined under FACS using the DCFH-DA staining and presented graphically for CVLME treatment in MCF-7 and WI-38 cells. (b) Intracellular ROS was visualized under the confocal microscope with ×400 magnification for CVLME treatment against MCF-7 cells
Click here to view |
High-performance liquid chromatography analysis
The HPLC analysis was performed to identify the probable bioactive compounds present in CVLME. As shown in [Figure 6], the HPLC evidence the presence of various phytochemicals including tannic acid, catechin, reserpine, and rutin. | Figure 6: High-performance liquid chromatography chromatogram of CVLME. (a) Peaks marked signify the retention peak of CVLME matched with the retention time of the known bioactive compounds in the same condition. (b) Chemical structure of the compounds identified through high-performance liquid chromatography
Click here to view |
| » Discussion | | |
In the past two decades, the scientific community has investigated treatment against many diseases using improved scientific technologies. However, some diseases including cancer remain elusive, especially from a therapeutic view. Natural resources have been playing a very significant part in the finding of new anticancer drugs. Among the natural resources, medicinal plants are the major contributors to drug development. To date, medicinal plants are the largest natural resource for the improvement of active anticancer candidates.[20],[21],[22] C. viscosum is a widely distributed medicinal plant and has been stated previously for the various potent activities. In this, we used the leaves of plant and prepared the 70% methanolic extract and tested its anticancer effect using various cancer cell lines. WST-1 is reduced to a chromogenic product formazan by cellular mitochondrial dehydrogenases generally produced by the viable cells.[23] The selective targeting of cancer cells is the key principle behind the development of anticancer drugs. CVLME also showed the selective targeting of MCF-7 cells. An ideal anticancer drug should inhibit the growth of cancer cells by arresting the cells in various cell cycle phases, and it has been evaluated. In recent years, the flow cytometer is widely used to determine the DNA content of the cells and the number of cells following the process of apoptotic.[24] From the results, it was deciphered that the CVLME selectively increases sub G1 population (apoptosis) with a slight increase in the synthetic (S) phase. The process of necrosis is usually occurred by disturbing the cellular architecture-like breakage of plasma membrane (PM), and in contrast, the process of apoptosis occurs without damaging the integrity of PM.[25] The PM is a bilayer structure and mostly composed of lipids and proteins. Phosphatidylserine (PS) is a phospholipid and presents mainly at the inner leaflet of PM. The two enzymes, namely, flippases and floppases regulate the translocation of these phospholipids through the membrane.[26] When a cell decides to undergo the process of apoptosis, it initiates the translocation of PS to the outer membrane. In the present study, CVLME-induced cell death was observed with the Annexin-V-FLUOS Staining kit to distinguish between apoptotic and necrotic populations. The assay is based on the observation of PS, which is located at the cytoplasmic side of PM and translocate to the surface of the cell during the initiation of apoptosis and this translocation of PS can be observed using the Annexin-V staining dye.[27] FITC-labeled Annexin-V (+) cells are detected by flow cytometry in combination with propidium iodide allowing characterization of the progressive stages of apoptosis. The results from [Figure 3] showed the early apoptosis started in MCF-7 from 50 μg/ml dose of CVLME. The highest dose of CVLME showed 39.91% of apoptotic population. During the process of apoptosis, enzymes such as endonucleases such as caspase 3-activated DNase (CAD) play an crucial role in initiation of DNA cleavage.[28] The characteristic changes, particularly in the nucleus were observed through a nuclear staining with the fluorescent dye DAPI.[29] As shown in [Figure 4], the intact nuclear morphology was witnessed in untreated MCF-7 cells. However, the disturbed nuclear morphology with fragmentation was observed in 200 μg/ml CVLME treated MCF-7 cells. The cellular ROS levels also impaired the proliferation of cells.[30] To evaluate the effect of CVLME treatment of MCF-7 cells, we used the 2′, 7′-dichlorodihydrofluorescein diacetate (DCFH-DA) dye. It penetrates into the cells and converted to its fluorescent form and which was further analyzed by the flow cytometer and confocal microscopy.[31],[32] The result showed the negligible ROS levels in CVLME treated normal WI-38 cells and the levels were very much elevated in MCF-7 cells upon CVLME treatment. A similar result was observed upon visualization under a confocal microscope. A review published by Wang et al. reported the list of almost 300 phytocompounds isolated from Clerodendrum genus plants.[17] Among the Clerodendrum genus, C. viscosum is one of the most studied medicinal plants for various biological activities. The presence of clerodone, viscosene, scutellarin, and hispidulin-7-0-glucuronide has been previously reported in Nandi et al. Moreover, Shendge et al. have previously isolated the ellagic acid[33] and apigenin[34] from the leaves of C. viscosum. In the present study, we have performed HPLC analysis and [Figure 6] shows the presence of various phytocompounds such as catechin, tannic acid, reserpine, and rutin in the CVLME extract. Catechin was previously established for potent antioxidant activities.[35] Tannic acid was shown previously for its activity against numerous degenerative diseases.[36] Furthermore, reserpine and rutin were shown for antioxidant and anticancer properties.[37] Recently, the ROS-elevated therapy is gaining attention in cancer treatments. Many drugs have been reported previously for their anticancer activity by inducing ROS in cancer cells.[34],[38],[39],[40] Moreover, many reports have supported the ROS inducing potential of catechins[41] and tannic acid.[42],[43] In the present study, using flow cytometry and confocal microscopy-based experiments, we have observed that CVLME induces ROS in MCF-7 cells dose dependently [Figure 5]. The ROS-inducing mechanism of CVLME may be due to the presence of catechin, tannic acid, and other phytochemicals present in it. The presence of such phytochemicals in CVLME possibly increases the genomic instability and further induces apoptosis in MCF-7 cells, as confirmed by the annexin V/PI staining [Figure 3] and confocal microscopy [Figure 4].
| » Conclusion | | |
The present finding demonstrates the anticancer potential of CVLME against MCF-7 cells. The cell proliferation assay reveals the toxic nature of CVLME against MCF-7 cell line but not toward other cancer cell lines and WI-38. Moreover, the flow cytometric data demonstrated the treatment of CVLME increased sub G1 population and induced early apoptosis in MCF-7 cells. Microscopic observations revealed the nuclear fragmentation and selective induction of ROS upon CVLME treatment. The selective ROS induction along with the presence of bioactive phytochemicals may be responsible for the cytotoxic nature of CVLME against MCF-7 cell line. In future, additional investigation requires to establish the exact anticancer mechanism of CVLME against breast cancer.
| » Acknowledgments | | |
AKS and TB are thankful to the CSIR and UGC, Government of India, for providing their fellowships.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| » References | | |
| 1. | Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 2007;9:49-89.  |
| 2. | Clément MV, Pervaiz S. Reactive oxygen intermediates regulate cellular response to apoptotic stimuli: An hypothesis. Free Radic Res 1999;30:247-52. |
| 3. | Le Bras M, Clément MV, Pervaiz S, Brenner C. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol Histopathol 2005;20:205-19. |
| 4. | Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424. |
| 5. | World Health Organization. Global Cancer Observatory. International Agency for Research on Cancer. Availablefrom: http://gco.iarc.fr. 2018. [Last accessed on 12 Aug 2019]. |
| 6. | Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001;30:1191-212. |
| 7. | Su D, Cheng Y, Liu M, Liu D, Cui H, Zhang B, et al. Comparision of piceid and resveratrol in antioxidation and antiproliferation activities in vitro. PLoS One 2013;8:e54505. |
| 8. | Shebaby WN, El-Sibai M, Smith KB, Karam MC, Mroueh M, Daher CF. The antioxidant and anticancer effects of wild carrot oil extract. Phytother Res 2013;27:737-44. |
| 9. | Desai AG, Qazi GN, Ganju RK, El-Tamer M, Singh J, Saxena AK, et al. Medicinal plants and cancer chemoprevention. Curr Drug Metab 2008;9:581-91. |
| 10. | Nandi S, Lyndem LM. Clerodendrum viscosum: Traditional uses, pharmacological activities and phytochemical constituents. Nat Prod Res 2016;30:497-506. |
| 11. | Das A, Chaudhuri D, Ghate NB, Chatterjee A, Mandal N. Comparative assessment of phytochemicals and antioxidant potential of methanolic and aqueous extracts of Clerodendrum colebrookianum walp. leaf from North-East India. Int J Pharm Pharm Sci 2013;5:420-7. |
| 12. | Nagdeva, Katiyar PK, Singh R. Anticancer activity of leaves of Clerodendron Serratum Spreng. Am J PharmTech Res 2012;2:452-61. |
| 13. | Shrivastava N, Patel T. Clerodendrum and healthcare: An overview. Med Aromat Plant Sci Biotechnol 2007;1:142-50. |
| 14. | Sannigrahi S, Mazumder UK, Pal D, Mishra SL. Hepatoprotective potential of methanol extract of Clerodendrum infortunatum Linn. against CCl4 induced hepatotoxicity in rats. Pharmacogn Mag 2009;5:3949. |
| 15. | Gbedema SY, Emelia K, Francis A, Kofi A, Eric W. Wound healing properties and kill kinetics of Clerodendron splendens G. Don, a Ghanaian wound healing plant. Pharmacognosy Res 2010;2:63-8. |
| 16. | Kekuda TP, Shree VD, Noorain GS, Sahana BK, Raghavendra HL. Ethnobotanical uses, phytochemistry and pharmacological activities of Clerodendrum infortunatum L. (Lamiaceae): A review. J Drug Deliv Ther 2019;9:547-59. |
| 17. | Wang JH, Luan F, He XD, Wang Y, Li MX. Traditional uses and pharmacological properties of Clerodendrum phytochemicals. J Tradit Complement Med 2018;8:24-38. |
| 18. | Dey P, Chaudhuri D, Tamang S, Chaudhuri TK, Mandal N. In vitro antioxidant and free radical scavenging potential of Clerodendrum viscosum. Int J Pharm Bio Sci 2012;3:454-71. |
| 19. | Ghate NB, Chaudhuri D, Sarkar R, Sajem AL, Panja S, Rout J, et al. An antioxidant extract of tropical lichen, Parmotrema reticulatum, induces cell cycle arrest and apoptosis in breast carcinoma cell line MCF-7. PLoS One 2013;8:e82293. |
| 20. | Greenwell M, Rahman PK. Medicinal plants: Their use in anticancer treatment. Int J Pharm Sci Res 2015;6:4103-12. |
| 21. | Moraes DF, Mesquita LS, Amaral FM, de Sousa Ribeiro MN, Malik S. Anticancer drugs from plants. In: Malik S, editor. Biotechnology and Production of Anti-Cancer Compounds. Gewerbestrasse 11, 6330 Cham, Switzerland: Springer International Publishing AG; 2017. [doi 10.1007/978-3-319-53880-8_5]. |
| 22. | Iqbal J, Abbasi BA, Mahmood T, Kanwal S, Ali B, Shah SA, et al. Plant-derived anticancer agents: A green anticancer approach. Asian Pac J Trop Biomed 2017;7:1129-50. |
| 23. | Ishimaya M, Shiga M, Sasamoto K, Mizoguchi M. A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye. Chem Pharm Bull 1993;41:1118-22. |
| 24. | Darzynkiewicz Z, Huang X, Zhao H. Analysis of cellular DNA content by flow cytometry. Curr Protoc Immunol 2004. [doi: 10.1002/0471142735.im0507s60]. |
| 25. | Zhang Y, Chen X, Gueydan C, Han J. Plasma membrane changes during programmed cell deaths. Cell Res 2018;28:9-21. |
| 26. | Leventis PA, Grinstein S. The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys 2010;39:407-27. |
| 27. | Lauber K, Blumenthal SG, Waibel M, Wesselborg S. Clearance of apoptotic cells: Getting rid of the corpses. Mol Cell 2004;14:277-87. |
| 28. | Larsen BD, Sorensen CS. The caspase-activated DNase: Apoptosis and beyond. FEBS J 2017;284:1160-70. |
| 29. | Allen RT, Hunter WJ 3 rd, Agrawal DK. Morphological and biochemical characterization and analysis of apoptosis. J Pharmacol Toxicol Methods 1997;37:215-28. |
| 30. | Zhang Y, Zhai W, Zhao M, Li D, Chai X, Cao X, et al. Effects of iron overload on the bone marrow microenvironment in mice. PLoS One 2015;10:e0120219. |
| 31. | Dikalov S, Griendling KK, Harrison DG. Measurement of reactive oxygen species in cardiovascular studies. Hypertension 2007;49:717-27. |
| 32. | Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 1999;27:612-6. |
| 33. | Shendge AK, Basu T, Panja S, Chaudhuri D, Mandal N. An ellagic acid isolated from Clerodendrum viscosum leaves ameliorates iron-overload induced hepatotoxicity in Swiss albino mice through inhibition of oxidative stress and the apoptotic pathway. Biomed Pharmacother 2018;106:454-65. |
| 34. | Shendge AK, Chaudhuri D, Basu T, Mandal N. A natural flavonoid, apigenin isolated from Clerodendrum viscosum leaves, induces G2/M phase cell cycle arrest and apoptosis in MCF-7 cells through the regulation of p53 and caspase-cascade pathway. Clin Transl Oncol 2020;23:718-30. [doi.org/10.1007/s12094-020-02461-0]. |
| 35. | Yao LH, Jiang JM, Shi J, Tomas-Barberan FA, Datta N, Singanusong R et al. Flavonoids in food and their health benefits. Plant Foods Hum Nutr 2004;59:113-22. |
| 36. | Basu T, Panja S, Shendge AK, Das A, Mandal N. A natural antioxidant, tannic acid mitigates iron-overload induced hepatotoxicity in Swiss albino mice through ROS regulation. Environ Toxicol 2018;33:603-18. |
| 37. | Rice-Evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res 1995;22:375-83. |
| 38. | Kotamraju S, Chitambar CR, Kalivendi SV, Joseph J, Kalyanaraman B. Transferrin receptor-dependent iron uptake is responsible for doxorubicin-mediated apoptosis in endothelial cells: Role of oxidant-induced iron signaling in apoptosis. J Biol Chem 2002;277:17179-87. |
| 39. | Marullo R, Werner E, Degtyareva N, Moore B, Altavilla G, Ramalingam SS, et al. Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS One 2013;8:e81162. [doi.org/10.1371/journal.pone. 0081162]. |
| 40. | Dasari S, Tchounwou PB. Cisplatin in cancer therapy: Molecular mechanisms of action. Eur J Pharmacol 2014;740:364-78. |
| 41. | Farhan M, Khan HY, Oves M, Al-Harrasi A, Rehmani N, Arif H, et al. Cancer therapy by catechins involves redox cycling of copper ions and generation of reactive oxygen species. Toxins (Basel) 2016;8:37. |
| 42. | Nagesh PK, Chowdhury P, Hatami E, Jain S, Dan N, Kashyap VK, et al. Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells. Sci Rep 2020;10:980. |
| 43. | Zhang J, Chen D, Han DM, Cheng YH, Dai C, Wu XJ, et al. Tannic acid mediated induction of apoptosis in human glioma Hs 683 cells. Oncol Lett 2018;15:6845-50. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]
|
